Multi-Formula покрытие for ODFs: Tackling Combination Drug Challenges
Поделиться
As Oral Dissolvable Films (ODFs) expand their role in both фармацевтические and functional добавки, multi-ингредиент formulations have become a key development trend. Whether it’s drug combinations or synergistic nutrition (like vitamins and minerals), ensuring stable, uniform distribution of multiple actives on a single плёнка presents a serious technical challenge.
Industry Pain Points
Traditional single-раствор покрытие methods face the following limitations when formulating multi-ингредиент ODFs:
- Incompatible solubility leads to sedimentation or phase separation
- Uneven АФИ distribution affects растворение curve consistency
- Formulation ratios become unstable during scale-up
- Cross-interactions between actives hinder quality and соответствие
These issues severely limit the industrialization of combination ODFs. In фарма registration, poor растворение consistency can directly lead to rejection.
HUANGHAI’s Multi-Formula покрытие раствор
HUANGHAI has developed a patented stripe-style multi-formula покрытие process that enables precise zone-based покрытие on a shared substrate:
- Independent Zones: Physically separate each formulation area to prevent cross-contamination
- Micron-Level Precision: Achieved via blade-type покрытие, ensuring uniform thickness
- Flexible Design: Supports dual, triple, or more component zones per плёнка
- GMP Compatibility: Enables consistent, repeatable results for registered drug products
This technology is ideal for formulation screening during фармацевтический R&D, as well as functional food innovation at лаб and pilot scale.
Patent Backing
This покрытие method is protected under Chinese patent CN117323228A, viewable on Google Patents.
Recommended оборудование
- MJ150-L ОРД покрытие машина – For small- and medium-scale production
- MJ150 ОРД покрытие машина – For commercial-scale производство
Conclusion
Combination ODFs are driven by real-world market needs, but demand robust technical execution. HUANGHAI’s multi-formula покрытие innovation provides a scalable, compliant раствор from formulation to registration—making “multi-АФИ, one плёнка” a commercial reality.
*Features Huanghai's exclusive patented hot-air drying technology (Patent No. CN201668734U) ensuring uniform bottom-up heating.
Frequently Asked Questions
Q: What is the difference between an ОРД плёнка and a трансдермальный пластырь?
A: Oral Dissolving Films (ОРД) are placed on or under the tongue and dissolve within seconds to minutes, delivering APIs directly through the oral mucosa or via swallowing. Transdermal patches adhere to the skin and deliver APIs through the dermal layers into systemic circulation over hours to days. Despite different delivery routes, both are manufactured using similar растворитель-cast плёнка покрытие processes. Huanghai's MJ150 ОРД машина supports both applications on a single platform with approximately 2 working days of changeover time.
Q: What production output can I expect from a Huanghai ОРД машина?
A: The MJ150 produces 20,000 films/hour at commercial scale. The MJ150-L targets R&D and pilot production at 8,000–10,000 films/hour. For fully integrated lines, pair either машина with the MJF180 automatic cutting and packaging system (11,900 films/hr) or the more affordable EZ320 (9,000 films/hr). A complete MJ150 + MJF180 line can produce over 150 million finished pouches annually on a single-shift basis. Contact us for pricing and configuration details.
Q: What drying technology does Huanghai use for ОРД production?
A: Huanghai uses patented gradient hot-air drying (Patent CN201668734U), which applies a smooth progressive temperature drop rather than stepwise oven zones used by competitors. This results in more uniform плёнка thickness, reduced edge curl, and better АФИ distribution across the плёнка web. An optional far-infrared heating module adds 20–30% drying efficiency for растворитель-based formulations. This patented drying system is one of the key technical advantages that justifies Huanghai's position as the preferred ОРД оборудование supplier to Sinopharm, Shanghai фарма, and Fosun фарма.
Q: What are the GMP требования for ОРД production оборудование?
A: ОРД производство оборудование must comply with cGMP (21 CFR Parts 210/211) for US market products, and equivalent стандарты (EU GMP Annex 1, ChGMP) for other markets. Key требования: material contact surfaces must be 316L stainless steel or equivalent; CIP/SIP capability or documented cleaning validation; данные integrity controls meeting ALCOA+ principles (audit trails, access control). Huanghai ОРД машины meet these стандарты—all product contact surfaces use фармацевтический-grade materials, and the control system includes operator access logs and parameter change records. Request our GMP соответствие documentation.
Q: Can Huanghai машины produce stripe-coated or multi-formula ОРД films?
A: Yes. Huanghai holds a patent for multi-formula stripe покрытие (Patent CN117323228A), enabling two different АФИ formulations to be applied side-by-side in a single покрытие pass. This eliminates the need for multiple покрытие/drying cycles when producing combination-drug ОРД products. Competitors require manual multi-layer покрытие with drying intervals between each formula. This capability is particularly valuable for fixed-dose combination products (e.g., dual-АФИ ODFs for cardiovascular or CNS indications) where покрытие efficiency directly impacts production economics.
Explore Complete ОРД & ТДДС производство Solutions
Huanghai offers end-to-end ОРД плёнка production lines — from лаб-scale R&D (BY-300A / MJ150-L) to commercial производство (MJ150). GMP-certified and 21 CFR Part 11 compliant.
View ОРД Production Line Solutions → | Request a Quote
Подтвердите наши сертификаты соответствия. Shanghai Huanghai Pharmaceutical Instruments имеет сертификаты FDA / GMP / ISO для линий фармацевтического тестового оборудования и производства орально диспергируемых плёнок. Наши сертификаты →